Posted On: 02/19/2016 12:14:50 PM
Post# of 1525
Here are price/sales ratios for various sectors:
http://pages.stern.nyu.edu/~adamodar/New_Home...sdata.html
Pharmaceuticals come in at 4.37:1.
RXMD's current ratio is less than 1:1.
They're debt-free, year over year revenues are growing, and they're expanding their current market while simultaneously entering new markets.
I'd say there's quite a bit of upside from here as we flirt with the .04s.
http://pages.stern.nyu.edu/~adamodar/New_Home...sdata.html
Pharmaceuticals come in at 4.37:1.
RXMD's current ratio is less than 1:1.
They're debt-free, year over year revenues are growing, and they're expanding their current market while simultaneously entering new markets.
I'd say there's quite a bit of upside from here as we flirt with the .04s.
(2)
(0)
